- Home
- PMAX vs CDIO Comparison
PMAX vs CDIO Comparison
Compare PMAX & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMAX
- CDIO
- Stock Information
- Founded
- PMAX 2019
- CDIO 2017
- Country
- PMAX Hong Kong
- CDIO United States
- Employees
- PMAX N/A
- CDIO N/A
- Industry
- PMAX
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- Sector
- PMAX
- CDIO Health Care
- Exchange
- PMAX Nasdaq
- CDIO Nasdaq
- Market Cap
- PMAX 7.9M
- CDIO 6.4M
- IPO Year
- PMAX 2024
- CDIO N/A
- Fundamental
- Price
- PMAX $0.37
- CDIO $4.50
- Analyst Decision
- PMAX
- CDIO Buy
- Analyst Count
- PMAX 0
- CDIO 1
- Target Price
- PMAX N/A
- CDIO $60.00
- AVG Volume (30 Days)
- PMAX 2.0M
- CDIO 40.4K
- Earning Date
- PMAX 04-28-2025
- CDIO 08-11-2025
- Dividend Yield
- PMAX N/A
- CDIO N/A
- EPS Growth
- PMAX N/A
- CDIO N/A
- EPS
- PMAX N/A
- CDIO N/A
- Revenue
- PMAX $4,694,079.00
- CDIO $19,902.00
- Revenue This Year
- PMAX N/A
- CDIO $1,434.82
- Revenue Next Year
- PMAX N/A
- CDIO $4,661.91
- P/E Ratio
- PMAX N/A
- CDIO N/A
- Revenue Growth
- PMAX N/A
- CDIO N/A
- 52 Week Low
- PMAX $0.28
- CDIO $3.22
- 52 Week High
- PMAX $4.70
- CDIO $53.10
- Technical
- Relative Strength Index (RSI)
- PMAX N/A
- CDIO 57.13
- Support Level
- PMAX N/A
- CDIO $3.43
- Resistance Level
- PMAX N/A
- CDIO $4.67
- Average True Range (ATR)
- PMAX 0.00
- CDIO 0.24
- MACD
- PMAX 0.00
- CDIO 0.21
- Stochastic Oscillator
- PMAX 0.00
- CDIO 100.00
About PMAX Powell Max Limited Class A Ordinary Shares
Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. All operations are carried in Hong Kong.
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.